Meropenem-Vaborbactam

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 348 publications

Managing KPC infections in daily practice: when BLBLIs are interchangeable - and when they are not.

Managing KPC infections in daily practice: when BLBLIs are interchangeable - and when they are not.

Journal: Current opinion in infectious diseases

Published: September 03, 2026

A comparative analysis of performance and time-to-result for VITEK REVEAL versus MicroScan during antimicrobial susceptibility testing for gram-negative bacteremia.

A comparative analysis of performance and time-to-result for VITEK REVEAL versus MicroScan during antimicrobial susceptibility testing for gram-negative bacteremia.

Journal: Microbiology spectrum

Published: September 02, 2026

Antibiotic Treatment of Severe Infections with Multiresistant Bacteria.

Antibiotic Treatment of Severe Infections with Multiresistant Bacteria.

Journal: Deutsches Arzteblatt international

Published: August 28, 2026

Emergence of mutHV76G in carbapenem-resistant Klebsiella pneumoniae disrupts DNA mismatch repair and results in a hypermutator phenotype.

Emergence of mutHV76G in carbapenem-resistant Klebsiella pneumoniae disrupts DNA mismatch repair and results in a hypermutator phenotype.

Journal: Antimicrobial agents and chemotherapy

Published: August 05, 2026

Addressing therapeutic options for KPC-3-producing ST307-Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies.

Addressing therapeutic options for KPC-3-producing ST307-Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies.

Journal: Antimicrobial agents and chemotherapy

Published: July 01, 2026

An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens.

An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens.

Journal: Expert opinion on drug metabolism & toxicology

Published: June 19, 2026

Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies.

Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies.

Journal: Frontiers in microbiology

Published: June 19, 2026

Activity of Aztreonam-avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa causing infections in patients hospitalized in hematology, oncology, and transplant units from United States medical centres (2019-2024).

Activity of Aztreonam-avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa causing infections in patients hospitalized in hematology, oncology, and transplant units from United States medical centres (2019-2024).

Journal: Diagnostic microbiology and infectious disease

Published: June 16, 2026

In vitro susceptibility of Stenotrophomonas maltophilia and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam.

In vitro susceptibility of Stenotrophomonas maltophilia and other carbapenem non-susceptible Gram-negative rods in the Pacific Northwest to cefiderocol and aztreonam-avibactam.

Journal: JAC-antimicrobial resistance

Published: June 10, 2026

Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.

Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: June 02, 2026

Pharmacokinetics, safety and population pharmacokinetics/pharmacodynamics analysis of meropenem-vaborbactam in Chinese healthy participants.

Pharmacokinetics, safety and population pharmacokinetics/pharmacodynamics analysis of meropenem-vaborbactam in Chinese healthy participants.

Journal: Frontiers in pharmacology

Published: May 22, 2026

Treatment of Post-Neurosurgical Ventriculitis and Scalp Infection Caused by Klebsiella pneumoniae Carbapenemase and New Delhi Metallo-β-Lactamase Co-Producing Carbapenem-Resistant Klebsiella pneumoniae: A Case Report.

Treatment of Post-Neurosurgical Ventriculitis and Scalp Infection Caused by Klebsiella pneumoniae Carbapenemase and New Delhi Metallo-β-Lactamase Co-Producing Carbapenem-Resistant Klebsiella pneumoniae: A Case Report.

Journal: Cureus

Published: May 15, 2026

Showing 1-12 of 348

Last Updated: 09/26/2026